Similar Counterregulatory Hormone Responses to Hypoglycemia with Basal Insulin Peglispro (BIL) vs. Insulin Glargine (GL) in Type 1 Diabetes

被引：0
|
作者：
Heise, Tim
Kapitza, Christoph
Nosek, Leszek
Lam, Eric Chen Quin
Choi, Siak Leng
Garhyan, Parag
Jacober, Scott J.
Porksen, Niels
Prince, Melvin J.
Linnebjerg, Helle
机构：
来源：
DIABETES | 2015年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
993-P
引用
收藏
页码：A252 / A253
页数：2
相关论文
共 50 条
  • [1] Similar counter-regulatory hormone responses to hypoglycaemia with Basal Insulin peglispro (BIL) versus insulin Glargine (GL) in type 1 diabetes
    Heise, T.
    Kapitza, C.
    Nosek, L.
    Lam, E.
    Choi, S.
    Garhyan, P.
    Jacober, S. J.
    Porksen, N.
    Prince, M. J.
    Linnebjerg, H.
    [J]. DIABETOLOGIA, 2015, 58 : S466 - S466
  • [2] Effect of exercise on Pharmacokinetics (PK) of Basal Insulin peglispro (BIL) and insulin Glargine (GL) in type 1 diabetes mellitus patients
    Linnebjerg, H.
    Lam, E.
    Choi, S.
    Knadler, M. P.
    Porksen, N.
    Sinha, V. P.
    Garhyan, P.
    Klein, O.
    Nosek, L.
    Heise, T.
    [J]. DIABETOLOGIA, 2015, 58 : S164 - S164
  • [3] Basal Insulin peglispro (BIL) demonstrates hepato-preferential action vs insulin Glargine (GL) in patients with type 1 diabetes mellitus Abstracts
    Mudaliar, S.
    Henry, R. R.
    Ciaraldi, T. P.
    Armstrong, D. A.
    Burke, P. M.
    Pettus, J. H.
    Garhyan, P.
    Choi, S. L.
    Jacober, S. J.
    Knadler, M. P.
    Lam, E. C. Q.
    Prince, M. J.
    Bose, N.
    Porksen, N. K.
    Linnebjerg, H.
    [J]. DIABETOLOGIA, 2015, 58 : S1 - S1
  • [4] Reduced intra-subject variability of Basal Insulin peglispro (BIL) compared to insulin Glargine (GL) in patients with type 1 diabetes mellitus Abstracts
    Lam, E.
    Garhyan, P.
    Linnebjerg, H.
    Choi, S.
    Knadler, M. P.
    Sinha, V. P.
    Sassenfeld, B. M.
    Nosek, L.
    Heise, T.
    [J]. DIABETOLOGIA, 2015, 58 : S1 - S2
  • [5] Effect of Exercise on Pharmacokinetics (PK) of Basal Insulin Peglispro (BIL) and Insulin Glargine (GL) in Type 1 Diabetes Mellitus (T1DM) Patients
    Linnebjerg, Helle
    Lam, Eric Chen Quin
    Choi, Siak Leng
    Knadler, Mary P.
    Porksen, Niels
    Sinha, Vikram P.
    Garhyan, Parag
    Klein, Oliver
    Nosek, Leszek
    Heise, Tim
    [J]. DIABETES, 2015, 64 : A253 - A253
  • [6] Lipid Changes during 26-Wk Treatment with the Novel Basal Insulin Peglispro (BIL) vs. Insulin Glargine (GL) or Insulin NPH in 6 IMAGINE Trials
    Ginsberg, Henry
    Cariou, Bertrand
    Orchard, Trevor J.
    Chen, Lei
    Luo, Junxiang
    Bastyr, Edward J., III
    Bue-Valleskey, Juliana
    Chang, Annette M.
    Ivanyi, Tibor
    Jacober, Scott J.
    Jacobson, Jennie G.
    Hoogwerf, Byron J.
    [J]. DIABETES, 2015, 64 : A251 - A251
  • [7] Reduced Nocturnal Hypoglycemia (Hypo) with Basal Insulin Peglispro (BIL) Compared with Insulin Glargine (GL): Pooled Analyses of 5 Randomized Controlled Trials
    Rosenstock, Julio
    Marre, Michel
    Qu, Yongming
    Jacober, Scott J.
    Prince, Melvin J.
    Chang, Annette M.
    Bastyr, Edward J., III
    [J]. DIABETES, 2015, 64 : A254 - A254
  • [8] Superior reduction of HbA1c in a double-blind, randomised study of basal insulin peglispro (BIL) vs insulin glargine (GL) in patients with type 1 diabetes: IMAGINE 3
    Lunt, H.
    Bergenstal, R. M.
    Franek, E.
    Travert, F.
    Mou, J.
    Hartman, M. L.
    Rosilio, M.
    Bastyr, E. J., III
    [J]. DIABETOLOGIA, 2015, 58 : S468 - S468
  • [9] Reduced Intra-subject Variability of Basal Insulin Peglispro (BIL) Compared with Insulin Glargine (GL) in Patients with Type 1 Diabetes Mellitus (T1DM)
    Lam, Eric Chen Quin
    Garhyan, Parag
    Linnebjerg, Helle
    Choi, Siak Leng
    Knadler, Mary P.
    Sinha, Vikram P.
    Sassenfeld, Bettina M.
    Nosek, Leszek
    Heise, Tim
    [J]. DIABETES, 2015, 64 : A25 - A25
  • [10] Superior HbA1c reduction with basal insulin peglispro (BIL) vs insulin glargine (GL) and preprandial insulin lispro in a double-blind study in type 2 diabetes patients: IMAGINE 4
    Chang, A. M.
    Blevins, T.
    Pieber, T. R.
    Vega, G. Colon
    Zhang, S.
    Bastyr, E. J., III
    [J]. DIABETOLOGIA, 2015, 58 : S470 - S471
12345